Article Versions Notes

Chang R, Chu X, Zhang J, Fu R, Feng C, Jia D, Wang R, Yan H, Li G, Li J. Liposome-Based Co-Immunotherapy with TLR Agonist and CD47-SIRPα Checkpoint Blockade for Efficient Treatment of Colon Cancer. Molecules. 2023; 28(7):3147. https://doi.org/10.3390/molecules28073147

Chang, Rui, Xiaohong Chu, Jibing Zhang, Rongrong Fu, Changshun Feng, Dianlong Jia, Rui Wang, Hui Yan, Guangyong Li, and Jun Li. 2023. "Liposome-Based Co-Immunotherapy with TLR Agonist and CD47-SIRPα Checkpoint Blockade for Efficient Treatment of Colon Cancer" Molecules 28, no. 7: 3147. https://doi.org/10.3390/molecules28073147

Chang, R., Chu, X., Zhang, J., Fu, R., Feng, C., Jia, D., Wang, R., Yan, H., Li, G., & Li, J. (2023). Liposome-Based Co-Immunotherapy with TLR Agonist and CD47-SIRPα Checkpoint Blockade for Efficient Treatment of Colon Cancer. Molecules, 28(7), 3147. https://doi.org/10.3390/molecules28073147